Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Antibiotics
Sort By
Newest First
1 / 2
1 / 2
Molecular Machines
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-24-NI-02
Jan 22, 2024
Antibiotic Resistance
Antibiotic Resistance: Advances in Understanding and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-07
Oct 11, 2022
Antimicrobial
Preserving the Value of Critical Anti-Infectives
Centrient Pharmaceuticals
PAO-04-22-R221-20
Apr 14, 2021
Antibiotics
Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe
Sandoz
PR-M07-20-NI-38
Jul 27, 2020
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001
Jul 01, 2020
Molecules
Molecules that Changed Medicine
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-002
Jul 01, 2020
Novel Antibiotics
Applying a Synthetic Approach to the Development of a New Generation of Antibiotics
James Graham
Recce Pharmaceuticals Ltd.
PAP-Q2-20-CL-019
Jul 01, 2020
FDA Approval
FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia
U.S. Food & Drug Administration
PR-M08-19-NI-061
Aug 21, 2019
Antibiotics
UK Hopes Subscription Payment Model Will Drive Innovation in Antibiotics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-006
Aug 01, 2019
Priority Review
Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-005
Jul 01, 2019
Antibiotic Resistant
FIU Scientists Discover New Arsenic-Based Broad-Spectrum Antibiotic
Florida International University
PR-M04-19-NI-058
Apr 18, 2019
Antibiotics
Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods
Nice Insight
PR-M11-18-NI-052
Nov 15, 2018
Investment
Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections
Qpex Biopharma
PR-M10-18-NI-087
Oct 25, 2018
Antibiotics
PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections
PolyPid
PR-M10-18-NI-070
Oct 19, 2018
Antibiotics
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
Menarini Group
PR-M10-18-NI-048
Oct 15, 2018
Drug Development
New Antibiotic to be Tested against Potential Bioweapons
Emilie Branch
Pharma's Almanac
PAO-M07-18-NI-009
Jul 17, 2018
Antibiotic Resistance
Roche PCT assay cleared for expanded use - Important tool in antibiotic resistance crisis
Roche
PR-M07-18-NI-049
Jul 16, 2018
Innovation
Funding Round Will Boost Efforts to Develop Antibiotic for Alzheimer’s Disease
Nigel Walker
Nice Insight
PAO-M06-18-NI-005
Jun 05, 2018
Antibiotics
Macrolide Attracts Funding and Executive Talent
Nigel Walker
Nice Insight
PAO-M04-18-NI-004
Apr 04, 2018
Antibiotic-Resistant
ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria
ABAC Therapeutics
PR-M02-18-NI-78
Feb 21, 2018
